APO RESEARCH · REPORT
In Vitro Diagnostics (IVDs) Products Contract Manufacturing
Selected research
Industry Research
In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Research Report 2026
Market perspective
The global In Vitro Diagnostics (IVDs) Products Contract Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the In Vitro Diagnostics (IVDs) Products Contract Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the In Vitro Diagnostics (IVDs) Products Contract Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the In Vitro Diagnostics (IVDs) Products Contract Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of In Vitro Diagnostics (IVDs) Products Contract Manufacturing include Jabil Inc., Sanmina Corporation, TE Connectivity, Savyon Diagnostics, West Pharmaceutical Services, Inc., Thermofisher, Celestica Inc., Biofortuna and Invetech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global In Vitro Diagnostics (IVDs) Products Contract Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to In Vitro Diagnostics (IVDs) Products Contract Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market by Company
Jabil Inc.
Sanmina Corporation
TE Connectivity
Savyon Diagnostics
West Pharmaceutical Services, Inc.
Thermofisher
Celestica Inc.
Biofortuna
Invetech
Cenogenics Corporation
In-Vitro Diagnostic Developers Inc
Maxim Biomedical, Inc
Elbit Systems Ltd. (KMC Systems, Inc.)
Nova Biomedical
LRE Medical
Cone Bioproducts
Biokit S.A.
Avioq, Inc
TCS Biosciences Ltd
Affinity Life Sciences, Inc
Coris BioConcept
Meridian Bioscience, Inc.
Merck KGaA
In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Type
IVD Consumables
IVD Equipment
In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Application
Assay Development Services
Manufacturing Services
Others
In Vitro Diagnostics (IVDs) Products Contract Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostics (IVDs) Products Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostics (IVDs) Products Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostics (IVDs) Products Contract Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In Vitro Diagnostics (IVDs) Products Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IVD Consumables
- IVD Equipment
Applications
- Assay Development Services
- Manufacturing Services
- Others
Companies covered
- Jabil Inc.
- Sanmina Corporation
- TE Connectivity
- Savyon Diagnostics
- West Pharmaceutical Services, Inc.
- Thermofisher
- Celestica Inc.
- Biofortuna
- Invetech
- Cenogenics Corporation
- In-Vitro Diagnostic Developers Inc
- Maxim Biomedical, Inc
- Elbit Systems Ltd. (KMC Systems, Inc.)
- Nova Biomedical
- LRE Medical
- Cone Bioproducts
- Biokit S.A.
- Avioq, Inc
- TCS Biosciences Ltd
- Affinity Life Sciences, Inc
- Coris BioConcept
- Meridian Bioscience, Inc.
- Merck KGaA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 In Vitro Diagnostics (IVDs) Products Contract Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 IVD Consumables
- 2.2.3 IVD Equipment
- 2.3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Assay Development Services
- 2.3.3 Manufacturing Services
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Breakdown Data by Type
- 3.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Forecasted Market Size by Type (2027-2032)
4 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Breakdown Data by Application
- 4.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Perspective (2021-2032)
- 5.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Growth Trends by Region
- 5.2.1 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Dynamics
- 5.3.1 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Trends
- 5.3.2 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Drivers
- 5.3.3 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Challenges
- 5.3.4 In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players by Revenue
- 6.1.1 Global Top In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of In Vitro Diagnostics (IVDs) Products Contract Manufacturing Head Office and Area Served
- 6.4 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Players, Product Type & Application
- 6.5 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Manufacturers Established Date
- 6.6 Global In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size (2021-2032)
- 7.2 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2021-2026)
- 7.4 North America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size (2021-2032)
- 8.2 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size (2021-2032)
- 10.2 South America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2021-2026)
- 10.4 South America In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa In Vitro Diagnostics (IVDs) Products Contract Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Jabil Inc.
- 12.1.1 Jabil Inc. Company Information
- 12.1.2 Jabil Inc. Business Overview
- 12.1.3 Jabil Inc. Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.1.4 Jabil Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.1.5 Jabil Inc. Recent Developments
- 12.2 Sanmina Corporation
- 12.2.1 Sanmina Corporation Company Information
- 12.2.2 Sanmina Corporation Business Overview
- 12.2.3 Sanmina Corporation Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.2.4 Sanmina Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.2.5 Sanmina Corporation Recent Developments
- 12.3 TE Connectivity
- 12.3.1 TE Connectivity Company Information
- 12.3.2 TE Connectivity Business Overview
- 12.3.3 TE Connectivity Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.3.4 TE Connectivity In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.3.5 TE Connectivity Recent Developments
- 12.4 Savyon Diagnostics
- 12.4.1 Savyon Diagnostics Company Information
- 12.4.2 Savyon Diagnostics Business Overview
- 12.4.3 Savyon Diagnostics Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.4.4 Savyon Diagnostics In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.4.5 Savyon Diagnostics Recent Developments
- 12.5 West Pharmaceutical Services, Inc.
- 12.5.1 West Pharmaceutical Services, Inc. Company Information
- 12.5.2 West Pharmaceutical Services, Inc. Business Overview
- 12.5.3 West Pharmaceutical Services, Inc. Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.5.4 West Pharmaceutical Services, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.5.5 West Pharmaceutical Services, Inc. Recent Developments
- 12.6 Thermofisher
- 12.6.1 Thermofisher Company Information
- 12.6.2 Thermofisher Business Overview
- 12.6.3 Thermofisher Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.6.4 Thermofisher In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.6.5 Thermofisher Recent Developments
- 12.7 Celestica Inc.
- 12.7.1 Celestica Inc. Company Information
- 12.7.2 Celestica Inc. Business Overview
- 12.7.3 Celestica Inc. Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.7.4 Celestica Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.7.5 Celestica Inc. Recent Developments
- 12.8 Biofortuna
- 12.8.1 Biofortuna Company Information
- 12.8.2 Biofortuna Business Overview
- 12.8.3 Biofortuna Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.8.4 Biofortuna In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.8.5 Biofortuna Recent Developments
- 12.9 Invetech
- 12.9.1 Invetech Company Information
- 12.9.2 Invetech Business Overview
- 12.9.3 Invetech Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.9.4 Invetech In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.9.5 Invetech Recent Developments
- 12.10 Cenogenics Corporation
- 12.10.1 Cenogenics Corporation Company Information
- 12.10.2 Cenogenics Corporation Business Overview
- 12.10.3 Cenogenics Corporation Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.10.4 Cenogenics Corporation In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.10.5 Cenogenics Corporation Recent Developments
- 12.11 In-Vitro Diagnostic Developers Inc
- 12.11.1 In-Vitro Diagnostic Developers Inc Company Information
- 12.11.2 In-Vitro Diagnostic Developers Inc Business Overview
- 12.11.3 In-Vitro Diagnostic Developers Inc Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.11.4 In-Vitro Diagnostic Developers Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.11.5 In-Vitro Diagnostic Developers Inc Recent Developments
- 12.12 Maxim Biomedical, Inc
- 12.12.1 Maxim Biomedical, Inc Company Information
- 12.12.2 Maxim Biomedical, Inc Business Overview
- 12.12.3 Maxim Biomedical, Inc Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.12.4 Maxim Biomedical, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.12.5 Maxim Biomedical, Inc Recent Developments
- 12.13 Elbit Systems Ltd. (KMC Systems, Inc.)
- 12.13.1 Elbit Systems Ltd. (KMC Systems, Inc.) Company Information
- 12.13.2 Elbit Systems Ltd. (KMC Systems, Inc.) Business Overview
- 12.13.3 Elbit Systems Ltd. (KMC Systems, Inc.) Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.13.4 Elbit Systems Ltd. (KMC Systems, Inc.) In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.13.5 Elbit Systems Ltd. (KMC Systems, Inc.) Recent Developments
- 12.14 Nova Biomedical
- 12.14.1 Nova Biomedical Company Information
- 12.14.2 Nova Biomedical Business Overview
- 12.14.3 Nova Biomedical Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.14.4 Nova Biomedical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.14.5 Nova Biomedical Recent Developments
- 12.15 LRE Medical
- 12.15.1 LRE Medical Company Information
- 12.15.2 LRE Medical Business Overview
- 12.15.3 LRE Medical Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.15.4 LRE Medical In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.15.5 LRE Medical Recent Developments
- 12.16 Cone Bioproducts
- 12.16.1 Cone Bioproducts Company Information
- 12.16.2 Cone Bioproducts Business Overview
- 12.16.3 Cone Bioproducts Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.16.4 Cone Bioproducts In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.16.5 Cone Bioproducts Recent Developments
- 12.17 Biokit S.A.
- 12.17.1 Biokit S.A. Company Information
- 12.17.2 Biokit S.A. Business Overview
- 12.17.3 Biokit S.A. Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.17.4 Biokit S.A. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.17.5 Biokit S.A. Recent Developments
- 12.18 Avioq, Inc
- 12.18.1 Avioq, Inc Company Information
- 12.18.2 Avioq, Inc Business Overview
- 12.18.3 Avioq, Inc Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.18.4 Avioq, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.18.5 Avioq, Inc Recent Developments
- 12.19 TCS Biosciences Ltd
- 12.19.1 TCS Biosciences Ltd Company Information
- 12.19.2 TCS Biosciences Ltd Business Overview
- 12.19.3 TCS Biosciences Ltd Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.19.4 TCS Biosciences Ltd In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.19.5 TCS Biosciences Ltd Recent Developments
- 12.20 Affinity Life Sciences, Inc
- 12.20.1 Affinity Life Sciences, Inc Company Information
- 12.20.2 Affinity Life Sciences, Inc Business Overview
- 12.20.3 Affinity Life Sciences, Inc Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.20.4 Affinity Life Sciences, Inc In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.20.5 Affinity Life Sciences, Inc Recent Developments
- 12.21 Coris BioConcept
- 12.21.1 Coris BioConcept Company Information
- 12.21.2 Coris BioConcept Business Overview
- 12.21.3 Coris BioConcept Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.21.4 Coris BioConcept In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.21.5 Coris BioConcept Recent Developments
- 12.22 Meridian Bioscience, Inc.
- 12.22.1 Meridian Bioscience, Inc. Company Information
- 12.22.2 Meridian Bioscience, Inc. Business Overview
- 12.22.3 Meridian Bioscience, Inc. Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.22.4 Meridian Bioscience, Inc. In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.22.5 Meridian Bioscience, Inc. Recent Developments
- 12.23 Merck KGaA
- 12.23.1 Merck KGaA Company Information
- 12.23.2 Merck KGaA Business Overview
- 12.23.3 Merck KGaA Revenue in In Vitro Diagnostics (IVDs) Products Contract Manufacturing Business (2021-2026)
- 12.23.4 Merck KGaA In Vitro Diagnostics (IVDs) Products Contract Manufacturing Product Portfolio
- 12.23.5 Merck KGaA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst